Sigrid B Sando

Summary

Affiliation: Norwegian University of Science and Technology
Country: Norway

Publications

  1. pmc APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway
    Sigrid B Sando
    Department of Neuroscience, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
    BMC Neurol 8:9. 2008
  2. pmc ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease
    Christopher W Medway
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Mol Neurodegener 9:11. 2014
  3. pmc Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study
    Minerva M Carrasquillo
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Mol Neurodegener 6:54. 2011
  4. pmc Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
    Mariet Allen
    Mayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA
    Mol Neurodegener 7:13. 2012
  5. doi request reprint Risk-reducing effect of education in Alzheimer's disease
    Sigrid Botne Sando
    Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
    Int J Geriatr Psychiatry 23:1156-62. 2008
  6. pmc Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study
    Camilla Lauridsen
    Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology Trondheim, Norway
    Front Aging Neurosci 8:30. 2016
  7. pmc Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study
    Guro Berge
    Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, NO, 7491, Norway
    BMC Neurol 16:180. 2016
  8. doi request reprint Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies
    Krisztina K Johansen
    Department of Neuroscience, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    Parkinsonism Relat Disord 16:307-15. 2010
  9. pmc Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
    Guro Berge
    Faculty of Medicine, Department of Neuroscience, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    J Neurol Neurosurg Psychiatry 85:1227-31. 2014
  10. pmc Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies
    John V Pearson
    Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
    Am J Hum Genet 80:126-39. 2007

Collaborators

  • Linda R White
  • Geir Bråthen
  • Ingvild Saltvedt
  • Stian Lydersen
  • Jan O Aasly
  • Inger J Bakken
  • Arvid Rongve
  • Dag Aarsland
  • Krisztina K Johansen
  • Grethe Albrektsen
  • R Heun
  • Eric Reiman
  • Frank Jessen
  • Michael Hutton
  • David W Craig
  • Andreas Papassotiropoulos
  • Guro Berge
  • Camilla Lauridsen
  • Ronald C Petersen
  • Maria Barcikowska
  • Dennis W Dickson
  • Fanggeng Zou
  • Zbigniew K Wszolek
  • Li Ma
  • Steven G Younkin
  • Minerva M Carrasquillo
  • Gøril R Grøntvedt
  • Ina Møller
  • Christopher W Medway
  • Owen A Ross
  • Nilufer Ertekin-Taner
  • Gina Bisceglio
  • Kevin Morgan
  • Mariet Allen
  • V Shane Pankratz
  • Julia E Crook
  • Neill R Graff-Radford
  • John V Pearson
  • Øyvind Salvesen
  • Adiba Shabnam
  • Guojun Bu
  • Tynickwa Mims
  • Samer Abdul-Hay
  • Neill Graff-Radford
  • Shane Pankratz
  • Joanna Siuda
  • Minerva Carrasquillo
  • Jin Jen
  • Fariborz Rakhshan
  • Ryan Palusak
  • High Seng Chai
  • Christopher N Rowley
  • Constantin Georgescu
  • Thuy Nguyen
  • Curtis S Younkin
  • Asha A Nair
  • Richard Miles
  • Debra Schultz
  • Ryan J Uitti
  • Sooraj Maharjan
  • Alexandra I Ortolaza
  • Christopher P Kolbert
  • Sumit Middha
  • Kimberly G Malphrus
  • Talisha A Hunter
  • Peter Passmore
  • Olivia Belbin
  • Gina D Bisceglio
  • Keith D Coon
  • Stacey Melquist
  • Jennifer A Webster
  • Szabolcs Szelinger
  • Dietrich A Stephan
  • Magdalini Tsolaki
  • Rebecca F Halperin
  • Marcel Brun
  • Makrina Daniilidou
  • Matthew J Huentelman
  • Waibhav D Tembe
  • Nils Homer
  • Victoria L Zismann
  • Thomas Beach
  • Heike Kolsch

Detail Information

Publications10

  1. pmc APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway
    Sigrid B Sando
    Department of Neuroscience, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
    BMC Neurol 8:9. 2008
    ....
  2. pmc ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease
    Christopher W Medway
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Mol Neurodegener 9:11. 2014
    ....
  3. pmc Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study
    Minerva M Carrasquillo
    Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
    Mol Neurodegener 6:54. 2011
    ..We performed meta-analyses of the association of these variants with LOAD and tested for association using logistic regression adjusted by age-at-diagnosis, gender, and APOE ε4 dosage...
  4. pmc Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
    Mariet Allen
    Mayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA
    Mol Neurodegener 7:13. 2012
    ..4,617 controls) and PD (678 PDs vs. 712 controls) for association with disease risk (case-controls), age-at-diagnosis (cases) and brain gene expression levels (autopsied subjects)...
  5. doi request reprint Risk-reducing effect of education in Alzheimer's disease
    Sigrid Botne Sando
    Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
    Int J Geriatr Psychiatry 23:1156-62. 2008
    ..To estimate the effect of education on the risk of Alzheimer's disease (AD)...
  6. pmc Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study
    Camilla Lauridsen
    Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology Trondheim, Norway
    Front Aging Neurosci 8:30. 2016
    ..We have examined levels of CSF Aβ43 in a 2-year longitudinal study of aMCI and early AD...
  7. pmc Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study
    Guro Berge
    Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, NO, 7491, Norway
    BMC Neurol 16:180. 2016
    ..However, results from α-synuclein measurements in cerebrospinal fluid (CSF) have been inconclusive, and to our knowledge, longitudinal studies of changes prior to the AD diagnosis have not been investigated...
  8. doi request reprint Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies
    Krisztina K Johansen
    Department of Neuroscience, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    Parkinsonism Relat Disord 16:307-15. 2010
    ..However as yet there are no markers that unequivocally distinguish between PDD and DLB...
  9. pmc Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
    Guro Berge
    Faculty of Medicine, Department of Neuroscience, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    J Neurol Neurosurg Psychiatry 85:1227-31. 2014
    ..The role of APOE alleles in a Norwegian cohort of patients with DLB was therefore examined compared with patients with AD and healthy control individuals...
  10. pmc Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies
    John V Pearson
    Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
    Am J Hum Genet 80:126-39. 2007
    ....